Key molecules that inhibit hepatitis C virus production identifiedMarch 11th, 2009 - 1:50 pm ICT by ANI
Washington, Mar 11 (ANI): Researchers from Scripps Florida have identified a potential therapeutic target for hepatitis C.
The research tem led by Professor Donny Strosberg has found that peptides (molecules of two or more amino acids) derived from the core protein of hepatitis C inhibits the production of the actual virus.
“We went for the simplest solution, taking a peptide from core to see if we could block the interaction,” Strosberg said, “and it did.”
One of the critical problems in developing drugs for HCV is that it mutates at such prodigious rates.
An RNA virus like hepatitis C can mutate at a rate estimated as high as one million times that of DNA viruses; in contrast, DNA viruses contain an enzyme (polymerase) that acts as something of a proof reader to ensure that newly transcribed DNA strands are the same as the original, helping to reduce mutations.
The researchers hope that the new discovery will help in developing improved anti-hepatitis C virus drugs.
The researchers have discovered two peptides that inhibited HCV production by 68 percent and 63 percent, respectively; a third related peptide showed 50 percent inhibition.
“In one sense, the ongoing issue with hepatitis C is that there are still so very few drugs to treat the virus and very few tools to study it,” Strosberg said.
“We set out to develop new tools and to identify a new target core, the capsid protein.
By targeting the interactions of core with itself or other proteins, we could reduce the problem of rapid mutation not only because the core protein mutates significantly less, but also because mutations that would affect the interface between core and itself or other proteins would often be more likely to deactivate the virus, in contrast to mutations in viral enzymes which often lead to increased resistance to drugs,” Strosberg added.
The study appears in the Journal of General Virology. (ANI)
- Hepatitis C virus infection linked to fat enzyme in liver cells - Oct 11, 2010
- New generation of drugs to cure hepatitis C - Aug 14, 2010
- Integrate Hepatitis C testing with HIV: NGOs - Oct 21, 2011
- Hepatitis C vaccine undergoing trials - Aug 16, 2012
- Complete structure of HIV's outer shell revealed - Jan 20, 2011
- New therapy could help beat Hepatitis C virus - Jan 17, 2012
- Protein key to hepatitis C virus replication identified - Aug 15, 2009
- Study offers potential new targets for novel anti-HIV drugs - Mar 26, 2011
- 'Chaperone' enzyme could help cells tolerate cancer-causing DNA damage - Jan 19, 2011
- Clinical trial offers hope for Hepatitis C patients - Mar 15, 2011
- All mammalian genes can be set on pause - Apr 30, 2010
- New vaccine technology shows promise against hepatitis C virus - Feb 24, 2011
- Coffee can cure hepatitis C - Jun 08, 2011
- Drug cocktail shows promise against hepatitis C - Mar 31, 2011
- Scientists isolate gene that protects against Alzheimer's - Jul 13, 2012
Tags: amino acids, capsid protein, core protein, critical problems, dna strands, dna viruses, hcv, hepatitis c, hepatitis c virus, journal of general virology, new discovery, one million times, peptides, polymerase, proof reader, rna virus, scripps florida, therapeutic target, viral enzymes, virus production